The size of the European Anaesthesia & Respiratory Devices Market was worth USD 6.40 billion in 2021. It is further estimated to be growing at a CAGR of 8.65% and worth USD 9.69 billion by 2026.
The anesthetic devices are intended to be used in all surgeries and supply a continuous flow of medical gases mixed with anesthetic vapors delivered to patients at a protected pressure and flow. Respiratory devices are a medical specialty decisive on treatment, management, control, diagnostic, evaluation, and care of patients with the cardiopulmonary system's deficiencies.
Speedy technological advancements taking place in these products are likely to lead towards the accessibility of better options for healthcare practitioners and patients, thus promoting anesthesia and respiratory devices market growth. Furthermore, the rising base of the elderly population and increasing environmental pollution rates are also expected to drive market growth. Stringent regulations for the market are hampering the growth of this market.
This research report on the European Anaesthesia and Respiratory Devices Market segmented and sub-segmented into the following categories.
By Device:
By Region:
Regionally, Europe is the second-largest region in the Global Anaesthesia and Respiratory Devices Market.
Some of the notable companies leading the European Anaesthesia & Respiratory Devices Market Profiled in the Report are Philips Healthcare, OSI Systems, Mindray, GE Healthcare, Draegerwerk AG, Masimo, Getinge Group, Fisher and Paykel, Covidien, Airsep Corp, Alung Technologies Inc, Bomimed Inc, 3M, Carefusion Inc, Astra Zeneca, Invacare, ResMed, Teleflex Inc, and Smiths Medical.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Device
5.1.1 Introduction
5.1.2 Anaesthesia Devices
5.1.2.1 Anaesthesia Machines
5.1.2.2 Anaesthetic Monitors
5.1.2.3 Anaesthetic Vaporizers
5.1.2.4 Analgesic Machines
5.1.2.5 Anaesthetic Masks
5.1.2.6 Anaesthetic Accessories
5.1.3 Respiratory Devices
5.1.3.1 Humidifiers
5.1.3.2 Resuscitators
5.1.3.3 Breathing Circuits
5.1.3.4 Chambers
5.1.3.5 CPAP Devices
5.1.3.6 Masks
5.1.3.7 Oxygen Concentrators
5.1.3.8 Nebulizers
5.1.3.9 Ventilators
5.1.3.10 Inhalers
5.1.3.11 Tracheotomy Tubes
5.1.3.12 Oxygen Cannula
5.1.3.13 Capnographs
5.1.3.14 Spirometers
5.1.5 Y-o-Y Growth Analysis, By Device
5.1.6 Market Attractiveness Analysis, By Device
5.1.7 Market Share Analysis, By Device
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Device
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Device
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Device
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Device
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Philips Healthcare
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 OSI Systems and Mindray
8.3 GE Healthcare
8.4 Draegerwerk AG
8.5 Masimo
8.6 Getinge Group
8.7 Fisher and Paykel
8.8 Covidien
8.9 Airsep Corp.
8.10 Alung Technologies Inc.
8.11 Bomimed Inc.
8.12 3M
8.13 Carefusion Inc.
8.14 Astra Zeneca
8.15 Invacare
8.16 ResMed
8.17 Teleflex Inc.
8.18 Smiths Medical
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
